MicroRNA-183 functions as the tumor suppressor via inhibiting cellular invasion and metastasis by targeting MMP-9 in cervical cancer (Q38794399)

6 September 2017

title

MicroRNA-183 functions as the tumor suppressor via inhibiting cellular invasion and metastasis by targeting MMP-9 in cervical cancer (English)

1 reference

6 September 2017

1 reference

cervix uterine cancer

1 reference

1 reference

Dongmei Fan

1 reference

6 September 2017

Ying Wang

1 reference

6 September 2017

Pengwei Qi

1 reference

6 September 2017

Yawei Chen

1 reference

6 September 2017

Po Xu

1 reference

6 September 2017

Xianan Yang

1 reference

6 September 2017

Ximeng Jin

1 reference

6 September 2017

Xiaoyu Tian

1 reference

6 September 2017

language of work or name

English

0 references

publication date

9 February 2016

1 reference

6 September 2017

1 reference

6 September 2017

volume

141

1 reference

6 September 2017

1 reference

6 September 2017

page(s)

166-174

1 reference

Cancer statistics for Hispanics/Latinos, 2015.

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

miR-135a leads to cervical cancer cell transformation through regulation of β-catenin via a SIAH1-dependent ubiquitin proteosomal pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

miR-133a inhibits cervical cancer growth by targeting EGFR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

MiR-124 represses vasculogenic mimicry and cell motility by targeting amotL1 in cervical cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

MiR‐96 and miR‐183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

MiR-183 promotes growth of non-small cell lung cancer cells through FoxO1 inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

miR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

Hairy/enhancer-of-split related with YRPW motif protein 1 promotes osteosarcoma metastasis via matrix metallopeptidase 9 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

MicroRNA-133a inhibits cell proliferation, colony formation ability, migration and invasion by targeting matrix metallopeptidase 9 in hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

miR-31 functions as an oncogene in cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

Down-regulation of miR-1246 in cervical cancer tissues and its clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

MicroRNA-491-5p suppresses cervical cancer cell growth by targeting hTERT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

miR-212/132 downregulates SMAD2 expression to suppress the G1/S phase transition of the cell cycle and the epithelial to mesenchymal transition in cervical cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

MiRNA-494 inhibits metastasis of cervical cancer through Pttg1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

Inhibitory effect and mechanisms of microRNA-146b-5p on the proliferation and metastatic potential of Caski human cervical cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

Downregulation of microRNA-145 is associated with aggressive progression and poor prognosis in human cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

Decreased expression of microRNA-126 is associated with poor prognosis in patients with cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

The microRNA-218~Survivin axis regulates migration, invasion, and lymph node metastasis in cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

MicroRNA-183 family conservation and ciliated neurosensory organ expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

Altered spinal microRNA-146a and the microRNA-183 cluster contribute to osteoarthritic pain in knee joints

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

Sex differences in the expression of lupus-associated miRNAs in splenocytes from lupus-prone NZB/WF1 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

Evaluation of single nucleotide polymorphisms in the miR-183-96-182 cluster in adulthood attention-deficit and hyperactivity disorder (ADHD) and substance use disorders (SUDs).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

The microRNA-183 cluster: the family that plays together stays together

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

MiR-183/-96/-182 cluster is up-regulated in most breast cancers and increases cell proliferation and migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

microRNA-183 plays as oncogenes by increasing cell proliferation, migration and invasion via targeting protein phosphatase 2A in renal cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

microRNA‑145 inhibits cell proliferation, migration and invasion by targeting matrix metallopeptidase-11 in renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

Osthole suppresses migration and invasion of A549 human lung cancer cells through inhibition of matrix metalloproteinase-2 and matrix metallopeptidase-9 in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.02.006

10.1016/J.YGYNO.2016.02.006

7 January 2021

Identifiers

DOI

1 reference

6 September 2017

1 reference